It is possible that the major title of the report Endomyocardial Fibrosis is not the name you expected. Please examine the basic synonyms specifying to discover the alternative name(s) and also problem subdivision(s) covered by this record.
- Davies’ condition
- fibroelastic endocarditis
- Loeffler endomyocardial fibrosis with eosinophilia
- Loeffler fibroplastic parietal endocarditis
- Loeffler’s illness
- biventricular fibrosis
- left ventricular fibrosis
- right ventricular fibrosis
Endomyocardial fibrosis (EMF) is a modern condition of unknown beginning (idiopathic) that could seriously influence the heart. Its most noticeable attribute is a gross modification in the makeup of the lining of the heart cavities (the endocardium) of one or both of the reduced chambers of the heart (the ventricles) bring about the substitute of healthy cells with fibrous tissue (fibrosis). This process is progressive and also leads to the constricting (constraint) of the right or left ventricular cavities. It might involve the shutoffs between the chambers of the heart along with the tendon-like cords that deal with the shutoffs to the ventricles (chordae tendineae).
Loeffler’s condition is a disease of the heart much like endomyocardial fibrosis. Some medical professionals concern it as an early stage of EMF, although this suggestion remains controversial. Loeffler’s condition is an uncommon disorder of unknown beginning, characterized by uncommon increases in the number of certain white blood cells (eosinophilia), and also like EMF, gross fibrosis of the endocardium, and inflammation of little blood vessels (arteritis).